Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium
References (84)
Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells
J. Pharm. Sci.
(1990)- et al.
Transport and permeability properties of human Caco-2 cells: an in vitro model of the intestinal epithelial cell barrier
J. Control. Release
(1990) - et al.
Active transport of amino acids by gamma-glutamyl transpeptidase through Caco-2 cell monolayers
Biochem. Biophys. Res. Commun.
(1991) - et al.
Uptake of the cephalosporin, Cephalexin by a dipeptide transport carrier in the human intestinal cell line, Caco-2
Biochim. Biophys. Acta
(1990) - et al.
Regulation of cytochrome P450 in cultured human colonie cells
Arch. Biochem. Biophys.
(1993) - et al.
Phase I and II biotransformations in living Caco-2 cells cultivated under serum-free conditions
Biochem. Pharm.
(1993) - et al.
Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco-2 cells
Life Sci.
(1991) - et al.
Glucuronidation in the Caco-2 human intestinal cell line: induction of UDP-glucuronosyltransferase 1∗6
Biochem. Pharmacol.
(1995) - et al.
Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7
Fed. Eur. Biochem. Soc. Lett.
(1994) Drug metabolism by cytochromes P450 in the liver and small bowel
Gastrointest. Pharmacol.
(1992)
Cytochromes P450 in the intestinal mucosa of man
Biochem. Pharmacol.
(1989)
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
Biochem. Biophys. Res. Commun.
(1991)
Epithelial transport of drugs in cell culture. II: effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of the intestinal epithelial (Caco-2) cells
J. Pharm. Sci.
(1990)
The mucus layer as a barrier to drug absorption in monolayers if human intestinal epithelial HT29-H goblet cells
Int. J. Pharm.
(1993)
Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly
J. Pharm. Sci.
(1991)
Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H+-coupled carriers at both apical and basal membranes
J. Biol. Chem.
(1993)
H+-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics
Biochim. Biophys. Acta
(1993)
H+ Coupled uphill transport of aminocephalosporins via the dipeptide transport system in rabbit intestinal brush-border membranes
J. Biol. Chem.
(1986)
Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit
J. Biol. Chem.
(1983)
A surface glycoprotein modulating drug permeability Chinese hamster ovary cell mutants
Biochim. Biophys. Acta
(1976)
Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells
Biochem. Biophys. Res. Commun.
(1993)
Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporin A transport
Biochem. Biophys. Res. Commun.
(1993)
Clinical pharmacokinetics of cyclosporin
Pharmacol. Ther.
(1989)
Glutathione S-transferase, cytochrome P450, and uridine 5′-diphosphate-giucuronosyltranferase in human small intestine and liver
Gastroenterology
(1989)
The role of cytochromes P-450 in cyclosporine metabolism
J. Am. Acad. Dermatol.
(1990)
First-pass metabolism of cyclosporin by the gut
Lancet
(1991)
CYP3A4 Expressed by insect cells infected with a recombinant Baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4
Arch. Biochem. Biophys.
(1995)
Intestinal absorption of xenobiotics
Functional morphology of the mucosa of the small intestine
Drug transport across gastrointestinal epithelia
In vitro systems for studying intestinal drug absorption
Med. Res. Rev.
(1995)
Expression of the multidrug resistance gene product (p-glycoprotein) in human normal and tumor tissues
J. Histochem. Cytochem.
(1990)
In vivo biliary excretion and the isolated perfused liver preparation
Enterocytelike differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture
Biol. Cell
(1983)
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
Gastroenterology
(1989)
Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa
Pharm. Res.
(1990)
Cell culture as models for drug absorption across the intestinal mucosa
Crit. Rev. Ther. Drug Carrier Syst.
(1991)
A model of human small intestinal absorptive cells. 1. Transport barrier
Pharm. Res.
(1991)
Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colon
J. Membr. Biol.
(1987)
Expression of dipeptidyl aminopeptidase IV during enterocytic differentiation of human colon cancer (Caco-2) cells
Int. J. Cancer
(1991)
Mechanism of L-α-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2)
Pharm. Res.
(1990)
Cited by (166)
Spatiotemporal manipulation metal–organic frameworks as oral drug delivery systems for precision medicine
2024, Coordination Chemistry ReviewsEnhanced stability and oral bioavailability of erlotinib by solid self nano emulsifying drug delivery systems
2022, International Journal of PharmaceuticsNanoemulsion for Improving the Oral Bioavailability of Hesperetin: Formulation Optimization and Absorption Mechanism
2021, Journal of Pharmaceutical SciencesSalidroside as a potential neuroprotective agent for ischemic stroke: a review of sources, pharmacokinetics, mechanism and safety
2020, Biomedicine and PharmacotherapyDrug and Gene Delivery Materials and Devices
2017, Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices
- 1
Present address: Department of Drug Metabolism and Pharmacokinetics, Du Pont Merck Pharmaceutical Co., Newark. DE 19714, USA.
Copyright © 1997 Published by Elsevier B.V.